USD 8.3
↑ 0.02 (0.24%)
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| NYXH | 0.2 | -12.2 | -12.6 | 8.5 | -19.2 | 70.1 | -64.7 | -65.4 | -65.4 | -65.4 |
| S&P 500 | -0.6 | -1.1 | 1.7 | 6.7 | 11.4 | 31.3 | 26.3 | 89.5 | 189.7 | 33382.1 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | NYXH |
| name | Nyxoah S.A. |
| price | 8.30 |
| changes percentage | 0.24 |
| change | 0.02 |
| day low | 8.30 |
| day high | 8.30 |
| year high | 20 |
| year low | 4 |
| market cap | 285191320 |
| price avg 50 | 9.05 |
| price avg 200 | 10.06 |
| exchange | NASDAQ |
| volume | 628 |
| avg volume | 65576 |
| open | 8.30 |
| previous close | 8.28 |
| eps | -1.82 |
| pe | -4.56 |
| earnings announcement | 2025-03-04T05:00:00.000+0000 |
| shares outstanding | 34360400 |
| timestamp | 2024-11-15 14:30:01 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001857190 | |||
| revenue | 4348000 | 3084000 | 40.99 |
| gross profit | 2692000 | 1934000 | 39.19 |
| gross profit ratio | 0.62 | 0.63 | -1.27 |
| research and development expenses | 27656000 | 15861000 | 74.36 |
| operating expenses | 47794000 | 34433000 | 38.80 |
| interest income | 2354000 | 6763000 | -65.19 |
| interest expense | 1207000 | 4320000 | -72.06 |
| ebitda | -43286000 | -27887000 | -55.22 |
| ebitdaratio | -9.96 | -8.35 | -19.30 |
| operating income | -45102000 | -32499000 | -38.78 |
| operating income ratio | -10.37 | -10.54 | 1.56 |
| net income | -43212000 | -31225000 | -38.39 |
| net income ratio | -9.94 | -10.12 | 1.84 |
| eps | -1.55 | -1.21 | -28.10 |
Revenue Growth: revenue increased to 4 million in 2023 from 3 million in 2022 representing a change of 40.99%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 3 million in 2023 from 2 million in 2022 representing a change of 39.19%. This indicates a sales profitability growth, which is a positive sign for the company.
Research and Development (R&D) Expenses: R&D Expenses increased to 28 million in 2023 from 16 million in 2022 representing a change of 74.36%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to -43 million in 2023 from -28 million in 2022 representing a change of -55.22%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to -45 million in 2023 from -32 million in 2022 representing a change of -38.78%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to -43 million in 2023 from -31 million in 2022 representing a change of -38.39%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Operating Expenses: Operating Expenses increased to 48 million in 2023 from 34 million in 2022 representing a change of 38.8%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
Earnings per Share (EPS): EPS increased to -1.55 in 2023 from -1.55 in 2022 representing a change of -28.1%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001857190 | |||
| revenue | 1266000 | 771000 | 64.20 |
| gross profit | 784000 | 490000 | 60.00 |
| gross profit ratio | 0.62 | 0.64 | -2.56 |
| research and development expenses | 7928000 | 7472000 | 6.10 |
| operating expenses | 15764000 | 13797000 | 14.26 |
| interest income | 703000 | 2069000 | -66.02 |
| interest expense | 672000 | 1445000 | -53.49 |
| ebitda | -15879000 | -11238000 | -41.30 |
| ebitdaratio | -12.54 | -14.58 | 13.95 |
| operating income | -14980000 | -13307000 | -12.57 |
| operating income ratio | -11.83 | -17.26 | 31.44 |
| net income | -17058000 | -13124000 | -29.98 |
| net income ratio | -13.47 | -17.02 | 20.84 |
| eps | -0.55 | -0.43 | -27.91 |
Revenue Growth: revenue decreased to 1 million in 2024Q3 from 1 million in 2024Q2 representing a change of 64.2%. This indicates a sales shrinking, which is a negative sign for the company.
Operating Expenses: Operating Expenses increased to 16 million in 2024Q3 from 14 million in 2024Q2 representing a change of 14.26%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
Earnings per Share (EPS): EPS increased to -0.55 in 2024Q3 from -0.55 in 2024Q2 representing a change of -27.91%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
Gross Profit: Gross Profit increased to 1 million in 2024Q3 from 0 million in 2024Q2 representing a change of 60.0%. This indicates a sales profitability growth, which is a positive sign for the company.
Research and Development (R&D) Expenses: R&D Expenses increased to 8 million in 2024Q3 from 7 million in 2024Q2 representing a change of 6.1%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to -16 million in 2024Q3 from -11 million in 2024Q2 representing a change of -41.3%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to -15 million in 2024Q3 from -13 million in 2024Q2 representing a change of -12.57%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to -17 million in 2024Q3 from -13 million in 2024Q2 representing a change of -29.98%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001857190 | |||
| total assets | 124157000 | 146071000 | -15.00 |
| total liabilities | 26135000 | 25747000 | 1.51 |
| total equity | 98112000 | 120324000 | -18.46 |
| cash and cash equivalents | 21610000 | 17888000 | 20.81 |
| short term investments | 36138000 | 76968000 | -53.05 |
| long term investments | 1166000 | 173000 | 573.99 |
| total current assets | 68351000 | 100260000 | -31.83 |
| total non current assets | 55806000 | 45811000 | 21.82 |
| total current liabilities | 14443000 | 14913000 | -3.15 |
| total non current liabilities | 11692000 | 10834000 | 7.92 |
| common stock | 4926000 | 4440000 | 10.95 |
| retained earnings | -160829000 | -118212000 | -36.05 |
| total debt | 12704000 | 11882000 | 6.92 |
Total Assets: Total Assets decreased to 124 million in 2023 from 146 million in 2022 representing a change of -15.0%. Suggesting a decrease in asset holdings.
Total Liabilities: Total Liabilities increased to 26 million in 2023 from 26 million in 2022 representing a change of 1.51%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to 98 million in 2023 from 120 million in 2022 representing a change of -18.46%. This indicates a decrease in shareholders' equity.
Short Term Investments: Short Term Investments decreased to 36 million in 2023 from 77 million in 2022 representing a change of -53.05%. This indicates a decrease in short-term investment holdings.
Total Current Assets: Total Current Assets decreased to 68 million in 2023 from 100 million in 2022 representing a change of -31.83%. This indicates a worsen liquidity position.
Retained Earnings: Retained Earnings decreased to -161 million in 2023 from -118 million in 2022 representing a change of -36.05%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 13 million in 2023 from 12 million in 2022 representing a change of 6.92%. This indicates an increase in overall debt burden.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 22 million in 2023 from 18 million in 2022 representing a change of 20.81%. This indicates an increase in available liquid assets.
Total Current Liabilities: Total Current Liabilities decreased to 14 million in 2023 from 15 million in 2022 representing a change of -3.15%. This indicates a lower short-term debt burden.
Common Stock: Common Stock increased to 5 in 2023 from 4 in 2022 representing a change of 10.95%. This indicates an increase in ownership interest.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001857190 | |||
| total assets | 142764000 | 148232000 | -3.69 |
| total liabilities | 38057000 | 28089000 | 35.49 |
| total equity | 104707000 | 120207000 | -12.89 |
| cash and cash equivalents | 28678000 | 27724000 | 3.44 |
| short term investments | 42299000 | 50061000 | -15.51 |
| long term investments | 0 | 1419000 | -100.00 |
| total current assets | 83582000 | 89675000 | -6.79 |
| total non current assets | 59182000 | 58557000 | 1.07 |
| total current liabilities | 15821000 | 16384000 | -3.44 |
| total non current liabilities | 22236000 | 11704999 | 89.97 |
| common stock | 5908000 | 5905000 | 0.05 |
| retained earnings | -200966000 | -185540000 | -8.31 |
| total debt | 23329000 | 12743000 | 83.07 |
Total Assets: Total Assets decreased to 143 million in 2024Q3 from 148 million in 2024Q2 representing a change of -3.69%. Suggesting a decrease in asset holdings.
Total Liabilities: Total Liabilities increased to 38 million in 2024Q3 from 28 million in 2024Q2 representing a change of 35.49%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to 105 million in 2024Q3 from 120 million in 2024Q2 representing a change of -12.89%. This indicates a decrease in shareholders' equity.
Short Term Investments: Short Term Investments decreased to 42 million in 2024Q3 from 50 million in 2024Q2 representing a change of -15.51%. This indicates a decrease in short-term investment holdings.
Total Current Assets: Total Current Assets decreased to 84 million in 2024Q3 from 90 million in 2024Q2 representing a change of -6.79%. This indicates a worsen liquidity position.
Retained Earnings: Retained Earnings decreased to -201 million in 2024Q3 from -186 million in 2024Q2 representing a change of -8.31%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 23 million in 2024Q3 from 13 million in 2024Q2 representing a change of 83.07%. This indicates an increase in overall debt burden.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 29 million in 2024Q3 from 28 million in 2024Q2 representing a change of 3.44%. This indicates an increase in available liquid assets.
Total Current Liabilities: Total Current Liabilities decreased to 16 million in 2024Q3 from 16 million in 2024Q2 representing a change of -3.44%. This indicates a lower short-term debt burden.
Common Stock: Common Stock increased to 6 in 2024Q3 from 6 in 2024Q2 representing a change of 0.05%. This indicates an increase in ownership interest.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001857190 | |||
| net change in cash | 3722000 | -117621000 | 103.16 |
| operating cash flow | -44778000 | -28756000 | -55.72 |
| free cash flow | -55740000 | -45105000 | -23.58 |
| capital expenditure | -10962000 | -16349000 | 32.95 |
| depreciation and amortization | 2360000 | 1932000 | 22.15 |
| deferred income tax | 0 | 0 | NaN |
| stock based compensation | 2611000 | 2698000 | -3.22 |
| accounts payables | 479000 | 615000 | -22.11 |
| inventory | -2433000 | -536000 | -353.92 |
| acquisitions net | -40663000 | 0 | NaN |
| investments in property plant and equipment | -90980000 | -16349000 | -456.49 |
| net cash used for investing activites | 32011000 | -89946000 | 135.59 |
| debt repayment | -1236000 | -1071000 | -15.41 |
| common stock issued | 18337000 | 255000 | 7,090.98 |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 16858000 | -983000 | 1,814.95 |
| cash at end of period | 21610000 | 17888000 | 20.81 |
| accounts receivables | -1540000 | 7000 | -22,100.00 |
| cash at beginning of period | 17888000 | 135509000 | -86.80 |
Net Change in Cash: Net Change in Cash increased to 4 million in 2023 from -118 million in 2022 representing a change of 103.16%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Stock-Based Compensation: Stock-Based Compensation decreased to 3 million in 2023 from 3 million in 2022 representing a change of -3.22%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 1 million in 2022 representing a change of -22.11%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables decreased to -2 million in 2023 from 0 million in 2022 representing a change of -22100.0%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Operating Cash Flow: Operating Cash Flow decreased to -45 million in 2023 from -29 million in 2022 representing a change of -55.72%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to -56 million in 2023 from -45 million in 2022 representing a change of -23.58%. This indicates a decrease in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure increased to -11 million in 2023 from -16 million in 2022 representing a change of 32.95%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
| 2024Q2 | 2024Q1 | Q/Q change % | |
|---|---|---|---|
| 0001857190 | |||
| operating cash flow | -11314000 | -11534000 | 1.91 |
| free cash flow | -11508000 | -13947000 | 17.49 |
| capital expenditure | -194000 | -2413000 | 91.96 |
| depreciation and amortization | 889000 | 610000 | 45.74 |
| deferred income tax | 0 | 0 | NaN |
| stock based compensation | 0 | 959000 | -100.00 |
| accounts receivables | 477000 | -767000 | 162.19 |
| accounts payables | 1961000 | -549000 | 457.19 |
| inventory | -1681000 | -102000 | -1,548.04 |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -194000 | -2413000 | 91.96 |
| net cash used for investing activites | -28202000 | 11885000 | -337.29 |
| debt repayment | 0 | -264000 | 100.00 |
| common stock issued | 45612000 | 62000 | 73,467.74 |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 45234000 | -245000 | 18,562.86 |
| net change in cash | 5647000 | 467000 | 1,109.21 |
| cash at end of period | 27724000 | 22077000 | 25.58 |
| cash at beginning of period | 22077000 | 21610000 | 2.16 |
Net Change in Cash: Net Change in Cash increased to 6 million in 2024Q2 from 0 million in 2024Q1 representing a change of 1109.21%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to -11 million in 2024Q2 from -12 million in 2024Q1 representing a change of 1.91%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to -12 million in 2024Q2 from -14 million in 2024Q1 representing a change of 17.49%. This indicates an increase in cash generated after accounting for capital expenditures.
Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q2 from 1 million in 2024Q1 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Capital Expenditure: Capital Expenditure increased to 0 million in 2024Q2 from -2 million in 2024Q1 representing a change of 91.96%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Accounts Payables: The absolute value of Accounts Payables increased to 2 million in 2024Q2 from 1 million in 2024Q1 representing a change of 457.19%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to 0 in 2024Q2 from -1 million in 2024Q1 representing a change of 162.19%. This suggests that the company is less capable of collecting payments from its customers.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q2 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 0.16 | 0.12 | 30.15 |
| net income per share | -1.55 | -1.21 | -27.76 |
| operating cash flow per share | -1.6 | -1.11 | -43.75 |
| free cash flow per share | -1.99 | -1.75 | -14.08 |
| cash per share | 2.06 | 3.67 | -43.80 |
| book value per share | 3.5 | 4.66 | -24.79 |
| tangible book value per share | 3.49 | 3.11 | 12.08 |
| shareholders equity per share | 3.51 | 4.66 | -24.73 |
| interest debt per share | 0.36 | 0.5 | -28.83 |
| market cap | 117404936.41 | 120321465.79 | -2.42 |
| enterprise value | 108498936.41 | 114315465.79 | -5.09 |
| pe ratio | -2.72 | -3.85 | 29.49 |
| price to sales ratio | 27.0 | 39.01 | -30.79 |
| pocfratio | -2.62 | -4.18 | 37.34 |
| pfcf ratio | -2.11 | -2.67 | 21.04 |
| pb ratio | 1.2 | 1.0 | 19.67 |
| ptb ratio | 1.2 | 1.0 | 19.67 |
| ev to sales | 24.95 | 37.07 | -32.68 |
| enterprise value over ebitda | -2.51 | -4.1 | 38.85 |
| ev to operating cash flow | -2.42 | -3.98 | 39.05 |
| ev to free cash flow | -1.95 | -2.53 | 23.20 |
| earnings yield | -0.37 | -0.26 | -41.83 |
| free cash flow yield | -0.47 | -0.37 | -26.65 |
| debt to equity | 0.09 | 0.07 | 24.91 |
| debt to assets | 0.07 | 0.06 | 19.83 |
| net debt to ebitda | 0.21 | 0.22 | -4.47 |
| current ratio | 4.73 | 6.72 | -29.61 |
| interest coverage | -37.37 | -7.52 | -396.71 |
| income quality | 1.0 | 0.96 | 4.80 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 4.75 | 5.82 | -18.38 |
| research and ddevelopement to revenue | 6.36 | 5.14 | 23.68 |
| intangibles to total assets | 0.0 | 0.27 | -98.63 |
| capex to operating cash flow | -0.24 | -0.57 | 56.94 |
| capex to revenue | 2.52 | 5.3 | -52.44 |
| capex to depreciation | 4.64 | 8.46 | -45.11 |
| stock based compensation to revenue | 0.6 | 0.87 | -31.36 |
| graham number | 11.04 | 11.26 | -1.93 |
| roic | -0.41 | -0.26 | -55.94 |
| return on tangible assets | -0.35 | -0.29 | -18.71 |
| graham net net | 1.26 | 2.75 | -53.97 |
| working capital | 53908000 | 85347000 | -36.84 |
| tangible asset value | 97557000 | 80352000 | 21.41 |
| net current asset value | 42216000 | 74513000 | -43.34 |
| invested capital | 62349000 | 130938000 | -52.38 |
| average receivables | 2266500 | 2143500 | 5.74 |
| average payables | 2987500 | 2133500 | 40.03 |
| average inventory | 2098500 | 614000 | 241.78 |
| days sales outstanding | 231.52 | 210.08 | 10.21 |
| days payables outstanding | 904.12 | 594.47 | 52.09 |
| days of inventory on hand | 730.66 | 279.94 | 161.01 |
| receivables turnover | 1.58 | 1.74 | -9.26 |
| payables turnover | 0.4 | 0.61 | -34.25 |
| inventory turnover | 0.5 | 1.3 | -61.69 |
| roe | -0.44 | -0.26 | -69.72 |
| capex per share | 0.39 | 0.63 | -38.10 |
ROE: Return on Equity (ROE) decreased to -0.44 on 2023-12-31 from -0.26 on 2022-12-31, representing a change of -69.72%. Suggesting that the company has not been generating high returns for its shareholders.
Current Ratio: Current Ratio decreased to 4.73 on 2023-12-31 from 6.72 on 2022-12-31, representing a change of -29.61%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to -2.72 on 2023-12-31 from -3.85 on 2022-12-31, representing a change of 29.49%. Indicating an increase in the relative valuation of the company's stock.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.09 on 2023-12-31 from 0.07 on 2022-12-31, representing a change of 24.91%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| NYXH | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 0.04 | 0.03 | 64.20 |
| net income per share | -0.55 | -0.43 | -29.98 |
| operating cash flow per share | None | -0.37 | NaN |
| free cash flow per share | None | -0.37 | NaN |
| cash per share | 2.31 | 2.53 | -8.75 |
| book value per share | 3.41 | 3.91 | -12.85 |
| tangible book value per share | 1.79 | 2.3 | -22.14 |
| shareholders equity per share | 3.41 | 3.91 | -12.89 |
| interest debt per share | 0.66 | 0.35 | 89.98 |
| market cap | 263629995.57 | 201391673.3 | 30.90 |
| enterprise value | 258280995.57 | 186410673.3 | 38.55 |
| pe ratio | -3.86 | -3.84 | -0.71 |
| price to sales ratio | 208.24 | 261.21 | -20.28 |
| pocfratio | 0 | -17.8 | 100.00 |
| pfcf ratio | 0 | -17.5 | 100.00 |
| pb ratio | 2.52 | 1.68 | 50.28 |
| ptb ratio | 2.52 | 1.68 | 50.28 |
| ev to sales | 204.01 | 241.78 | -15.62 |
| enterprise value over ebitda | -16.27 | -16.59 | 1.94 |
| ev to operating cash flow | 0 | -16.48 | 100.00 |
| ev to free cash flow | 0 | -16.2 | 100.00 |
| earnings yield | -0.06 | -0.07 | 0.71 |
| free cash flow yield | None | -0.06 | NaN |
| debt to equity | 0.19 | 0.08 | 143.99 |
| debt to assets | 0.14 | 0.06 | 120.67 |
| net debt to ebitda | 0.34 | 1.33 | -74.73 |
| current ratio | 5.28 | 5.47 | -3.48 |
| interest coverage | -22.29 | -9.21 | -142.06 |
| income quality | 0 | 0.86 | -100.00 |
| dividend yield | None | 0 | NaN |
| payout ratio | None | 0 | NaN |
| sales general and administrative to revenue | 6.09 | 0 | NaN |
| research and ddevelopement to revenue | 6.26 | 9.69 | -35.38 |
| intangibles to total assets | 0.35 | 0.33 | 4.35 |
| capex to operating cash flow | 0 | -0.02 | 100.00 |
| capex to revenue | None | 0.25 | NaN |
| capex to depreciation | 0 | 0.22 | -100.00 |
| stock based compensation to revenue | None | 0 | NaN |
| graham number | 6.52 | 6.13 | 6.40 |
| roic | -0.12 | -0.11 | -14.46 |
| return on tangible assets | -0.18 | -0.13 | -37.95 |
| graham net net | 1.29 | 1.76 | -26.80 |
| working capital | 67761000 | 73291000 | -7.55 |
| tangible asset value | 55149000 | 70833000 | -22.14 |
| net current asset value | 45525000 | 61586000 | -26.08 |
| invested capital | 125415000 | 130378000 | -3.81 |
| average receivables | 4052500 | 2790000 | 45.25 |
| average payables | 5612000 | 3648500 | 53.82 |
| average inventory | 5185000 | 4258000 | 21.77 |
| days sales outstanding | 390.71 | 304.55 | 28.29 |
| days payables outstanding | 1327.41 | 1317.97 | 0.72 |
| days of inventory on hand | 984.4 | 1632.81 | -39.71 |
| receivables turnover | 0.23 | 0.3 | -22.05 |
| payables turnover | 0.07 | 0.07 | -0.71 |
| inventory turnover | 0.09 | 0.06 | 65.87 |
| roe | -0.16 | -0.11 | -49.22 |
| capex per share | None | 0.01 | NaN |
ROE: Return on Equity (ROE) decreased to -0.16 on 2024-09-30 Q3 from -0.11 on 2024-06-30 Q2, representing a change of -49.22%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -3.86 on 2024-09-30 Q3 from -3.84 on 2024-06-30 Q2, representing a change of -0.71%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 5.28 on 2024-09-30 Q3 from 5.47 on 2024-06-30 Q2, representing a change of -3.48%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.19 on 2024-09-30 Q3 from 0.08 on 2024-06-30 Q2, representing a change of 143.99%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2024-11-08 18:46:48
Nyxoah S.A. (NASDAQ:NYXH ) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Mikaela Kirkwood - Corporate Communications and IR Manager Olivier Taelman - CEO Loic Moreau - CFO Conference Call Participants Adam Maeder - Piper Sandler Joe Federico - Stifel Suraj Kalia - Oppenheimer Ross Osborn - Cantor Fitzgerald David Rescott - Baird Operator Good day.
Sentiment: Negative
Publish Date: 2024-11-06 20:21:08
Nyxoah SA (NYXH) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.29 per share a year ago.
Sentiment: Positive
Publish Date: 2024-11-04 16:45:00
Nyxoah Appoints John Landry as Chief Financial Officer Current CFO, Loïc Moreau, to Transition into Role of President International Mont-Saint-Guibert, Belgium – November 4, 2024, 10:45pm CET / 4:45pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced the appointment of John Landry as Chief Financial Officer (CFO), effective November 4, 2024. This strategic appointment, in combination with the recent move to the United States of CEO Olivier Taelman, strengthens the Company's focus on the U.S. market.
Sentiment: Positive
Publish Date: 2024-10-30 11:06:25
Nyxoah (NYXH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sentiment: Positive
Publish Date: 2024-10-25 16:30:00
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 25, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. Vestal Point Capital On October 23, 2024, Nyxoah received a transparency notification from Vestal Point Capital following an acquisition or disposal of voting securities or voting rights.
Sentiment: Positive
Publish Date: 2024-10-22 16:30:00
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 Mont-Saint-Guibert, Belgium – October 22, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the third quarter 2024 on Wednesday, November 6, 2024, after market close. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.
Sentiment: Positive
Publish Date: 2024-10-15 16:30:00
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 15, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received three transparency notifications as detailed below. Jürgen Hambrecht On October 15, 2024, Nyxoah received a transparency notification from Jürgen Hambrecht and Jürgen Hambrecht's controlled undertaking JH Capital GmbH following an acquisition or disposal of voting securities or voting rights.
Sentiment: Neutral
Publish Date: 2024-10-09 16:30:00
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 9, 2024 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. BlackRock, Inc. On October 7, 2024, Nyxoah received a transparency notification from BlackRock, Inc. and related persons following a change to BlackRock's group structure.
Sentiment: Positive
Publish Date: 2024-10-07 17:00:00
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Raises $27 Million through its At-the-Market Offering Investment by a new U.S.-based healthcare investor, strengthening the balance sheet and reinforcing U.S. focus Mont-Saint-Guibert, Belgium – October 7, 2024, 11:00pm CET / 5:00pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company has sold 3.0 million shares raising $27.0 million in gross proceeds pursuant to the Company's $50 million at-the-market ("ATM") offering at a price per share equal to the market price on the Nasdaq Global Market at the time of sale. The shares were sold, based on interest received, to a single U.S.-based healthcare investor.
Sentiment: Positive
Publish Date: 2024-09-27 16:30:00
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update Additional clinical data on patients suffering from Obstructive Sleep Apnea (OSA) demonstrate a clinically significant 71.0% median reduction in Apnea-Hypopnea index (AHI) while sleeping supine at 12 months compared with baseline. 82.0% of patients who completed a polysomnography at 12 months had an AHI below 15, and 67.4% of patients who completed a polysomnography at 12 months had an AHI below 10.
Sentiment: Neutral
Publish Date: 2024-09-27 02:00:00
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), September 27, 2024 , 8.00am CET / 2.00am ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. BlackRock, Inc. On September 24, 2024, Nyxoah received a transparency notification from BlackRock, Inc. and related persons indicating that BlackRock Advisors, LLC went below the 3% threshold on September 20, 2024.
Sentiment: Positive
Publish Date: 2024-09-05 16:30:00
Nyxoah to Participate in Upcoming Investor Conferences Mont-Saint-Guibert, Belgium – September 5, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in three upcoming investor conferences in New York City. Olivier Taelman, Nyxoah's Chief Executive Officer, will deliver corporate updates at the Baird Global Healthcare Conference on Tuesday, September 10, 2024, at 12:15pm ET, the H.C. Wainwright 26th Annual Global Investment Conference on Wednesday, September 11, 2024, at 11:00am ET and the Cantor Global Healthcare Conference on Wednesday, September 18, 2024 at 1:55pm ET.
Sentiment: Positive
Publish Date: 2024-09-02 16:05:00
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
